ACMRACM Research, Inc.

ACM Research, Inc. (NASDAQ: ACMR) | Price: $80.28 | Today's Change: +6.17%

---

What Happened

ACM Research filed an 8-K with the SEC on September 30, 2026 (Items 8.01 and 9.01), disclosing selected financial results for its second fiscal quarter of 2026. The filing reveals revenue of $387.7 million for Q2 FY2026, alongside net income of $50.1 million and operating income of $57.5 million. Basic EPS came in at $0.79 and diluted EPS at $0.74, marking a significant milestone when viewed against the company's Q2 FY2019 revenue figure of $30.6 million also referenced in the filing's XBRL data — illustrating the scale of growth ACMR has achieved over that span.

Why It Matters

For investors, this disclosure puts hard numbers on the table for ACMR's most recent quarter. Revenue of $387.7 million and operating income of $57.5 million indicate that the company continues to generate meaningful top- and bottom-line results at scale. The stock's +6.17% move on the day of this report's publication suggests the market is reacting positively to the figures disclosed. The operating income margin implied by these figures — with operating income of $57.5 million on revenues of $387.7 million — works out to roughly 14.8%, offering a tangible read on profitability. Net income of $50.1 million translates to a net margin of approximately 12.9%, which investors will want to weigh against industry peers and the company's own recent trajectory. This follows our existing Initiating Coverage on ACMR published on September 4, 2026.

Analysis

The headline numbers suggest ACM Research is sustaining solid operating momentum in a semiconductor equipment environment that has remained closely watched for signs of demand softening or export-related headwinds. The contrast embedded in the filing itself — Q2 FY2019 revenue of $30.6 million versus Q2 FY2026 revenue of $387.7 million — underscores a roughly 12.7x revenue expansion over approximately seven years, a compound growth rate that few equipment makers can match.

The gap between operating income ($57.5M) and net income ($50.1M) — a difference of approximately $7.4 million — is worth monitoring in subsequent disclosures, as it may reflect interest expense, tax provisions, or other below-the-line items that can shift meaningfully quarter to quarter.

Key things to watch going forward:

• Geographic revenue mix: ACMR derives a substantial share of revenue from China-based customers, and any updated commentary on that exposure will be closely scrutinized given the ongoing trade and export control backdrop.
• Gross margin trajectory: The filing's structured data does not provide gross margin directly; investors will want to track how input costs and product mix are affecting profitability.
• Order backlog and customer concentration: Any supplemental disclosures attached under Item 9.01 may offer additional color on the pipeline.
• Full-year guidance: Whether management reaffirms, raises, or qualifies its forward outlook will be a critical signal.

The filing, while structured as an 8-K rather than a full quarterly report, nonetheless provides a meaningful earnings-level data point that investors and analysts will use to calibrate their models heading into the back half of fiscal 2026.

---

Disclaimer

This report is a news and informational summary based solely on publicly available SEC filing data and structured XBRL facts extracted from ACM Research's 8-K filed September 30, 2026. It does not constitute investment advice, a solicitation to buy or sell any security, or a research recommendation. No rating or price target is issued in this report. Investors should conduct their own due diligence and consult a qualified financial professional before making any investment decision. Past performance and historical growth rates are not guarantees of future results.

Existing Coverage

StockWatch has full coverage on ACMR, published 2026-09-04. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-09-30. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1680062/000162828026063896/acmr-20260930.htm